SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ZymoGenetics ZGEN
An SI Board Since February 2002
Posts SubjectMarks Bans Symbol
210 12 0 ZGEN
Emcee:  Mike McFarland Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
85>>I still don't know how to process the thawing issue. If indeed it tatuck-1/24/2008
84<i>So the CEO's comment about margin tells pretty much nothing about pDewDiligence_on_SI-1/22/2008
83The difference between a 70% and 90% margin is quite a bit in price. Like 3x. kenhott-1/22/2008
82Hi Tuck, OMRI's Evicel is the only other fibrin sealant competing with Baxtidos-1/21/2008
81Idos, I was a bit off in imagining the scenarios of how the thrombins would be tuck-1/21/2008
80Tuck, I was reading this from OMRI's home page: (http://www.omrix.com/produidos-1/20/2008
79Hi, Idos, >>Evithrom is supplied as ready to use liquid<< Not quittuck-1/20/2008
78> I don't think the marketing battle will be that tough.< Just 2 poinidos-1/20/2008
77COGS depends on many factors, of course, but the range is 11% (Biogen's AvonHarold Engstrom-1/19/2008
76<i>>Would you guys venture a guess as to what the normal margin or COGSDewDiligence_on_SI-1/19/2008
75Would you guys venture a guess as to what the normal margin or COGS for a biophatuck-1/19/2008
74Indeed. From the Department of Irony . . . ZGEN gets drug approved, tuck-1/18/2008
73Even KG is down.rkrw-1/18/2008
72<i>>What's curious is both zgen and omrix are getting slammed todayDewDiligence_on_SI-1/18/2008
71What's curious is both zgen and omrix are getting slammed today.rkrw-1/18/2008
70Thanks for that post. I added to my ZGEN position earlier today. In this marLJM-1/18/2008
69>>If rhThrombin is used in any of the surgeries (1st, 2nd or third etc) thtuck-1/18/2008
68<b>Oppenheimer Downgrades ZymoGenetics, Concerned About New Product's idos-1/18/2008
67<i>Which would be unnecessary if rhthrombin was used in the first surgery Clarksterh-1/17/2008
66David Miller made an interesting point not much discussed here . . . thatuck-1/17/2008
65Indeed, I've watched that, since I hold a bit from about $7 (sigh). And thetuck-1/17/2008
64IDIX hasn’t retreated much from its JPM pop.DewDiligence_on_SI-1/17/2008
63VRUS and RIGL stand out for pops that stuck. But good point, every pop has been rkrw-1/17/2008
62I was being a bit tongue in cheek there. One other factoid . . . shortuck-1/17/2008
61<i>…marketing against J&J and Omrix and the producers of bovine plasmaDewDiligence_on_SI-1/17/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News